Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease - PubMed (original) (raw)
. 2008 Dec 9;71(24):1986-92.
doi: 10.1212/01.wnl.0000336925.79704.9f.
D A Loewenstein, E Potter, J Appel, M T Greig, R Urs, Q Shen, A Raj, B Small, W Barker, E Schofield, Y Wu, H Potter
Affiliations
- PMID: 19064880
- PMCID: PMC2676975
- DOI: 10.1212/01.wnl.0000336925.79704.9f
Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease
R Duara et al. Neurology. 2008.
Abstract
Background: Despite convenience, accessibility, and strong correlation to severity of Alzheimer disease (AD) pathology, medial temporal lobe atrophy (MTA) has not been used as a criterion in the diagnosis of prodromal and probable AD.
Methods: Using a newly validated visual rating system, mean MTA scores of three bilateral medial temporal lobe structures were compared for subjects with no cognitive impairment (NCI) (n = 117), nonamnestic mild cognitive impairment (MCI) (n = 46), amnestic MCI (n = 45), and probable AD (n = 53). Correlations between MTA scores and neuropsychological test scores at baseline, and predictors of change in diagnosis at 1-year follow-up were evaluated.
Results: With NCI as the reference group, a mean MTA cut score of 1.33 yielded an optimal sensitivity/specificity of 85%/82% for probable AD subjects and 80%/82% for amnestic MCI subjects. MTA and Clinical Dementia Rating Sum of Boxes scores at baseline were independent and additive predictors of diagnosis at baseline, and of transition from NCI to MCI or from MCI to dementia at 1-year follow-up.
Conclusion: Medial temporal lobe atrophy (MTA) scores 1) distinguish probable Alzheimer disease (AD) and amnestic mild cognitive impairment (MCI) subjects from nonamnestic MCI and no cognitive impairment (NCI) subjects, 2) help predict diagnosis at baseline, and 3) predict transition from NCI to MCI and from MCI to probable AD. MTA scores should be used as a criterion in the clinical diagnosis of AD.
Figures
Figure 1 Visual rating system for assessing medial temporal atrophy (A) The three regions of interest are outlined in the right hemisphere in color (hippocampus = red; entorhinal cortex = blue; perirhinal cortex = green), all showing no atrophy (score = 0) in both hemispheres. (B) All structures have severe atrophy (score = 4), with the exception of the right perirhinal cortex, which has moderate atrophy.
Figure 2 Medial temporal atrophy from visual rating system vs clinical diagnosis Box plot of medial temporal atrophy score (average of left and right) for subjects diagnosed with no cognitive impairment (NCI), nonamnestic mild cognitive impairment (MCI), amnestic MCI, and probable Alzheimer disease (AD). The median visual rating system score is represented by a horizontal line within the shaded box. The top and bottom of the box represent the 75th and 25th percentiles. The lines that extend out the top and bottom are 1.5 times the interquartile range (IQR) (value of 75th minus 25th percentile) above and below the box. Open circles are outliers (1.5–3 times the IQR above the box). The asterisk is an extreme outlier (more than 3 times the IQR above the box).
Similar articles
- Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
Tam CW, Burton EJ, McKeith IG, Burn DJ, O'Brien JT. Tam CW, et al. Neurology. 2005 Mar 8;64(5):861-5. doi: 10.1212/01.WNL.0000153070.82309.D4. Neurology. 2005. PMID: 15753423 - Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors.
Appel J, Potter E, Bhatia N, Shen Q, Zhao W, Greig MT, Raj A, Barker WW, Potter H, Schofield E, Wu Y, Loewenstein DA, Duara R. Appel J, et al. AJNR Am J Neuroradiol. 2009 Nov;30(10):1870-6. doi: 10.3174/ajnr.A1693. Epub 2009 Jul 30. AJNR Am J Neuroradiol. 2009. PMID: 19643919 Free PMC article. - Magnetic resonance imaging predictors of cognition in mild cognitive impairment.
van de Pol LA, Korf ES, van der Flier WM, Brashear HR, Fox NC, Barkhof F, Scheltens P. van de Pol LA, et al. Arch Neurol. 2007 Jul;64(7):1023-8. doi: 10.1001/archneur.64.7.1023. Arch Neurol. 2007. PMID: 17620494 Clinical Trial. - Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.
Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J. Visser PJ, et al. J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):491-7. doi: 10.1136/jnnp.72.4.491. J Neurol Neurosurg Psychiatry. 2002. PMID: 11909909 Free PMC article. - The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old.
Barkhof F, Polvikoski TM, van Straaten EC, Kalaria RN, Sulkava R, Aronen HJ, Niinistö L, Rastas S, Oinas M, Scheltens P, Erkinjuntti T. Barkhof F, et al. Neurology. 2007 Oct 9;69(15):1521-7. doi: 10.1212/01.wnl.0000277459.83543.99. Neurology. 2007. PMID: 17923614
Cited by
- T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
Haris M, Yadav SK, Rizwan A, Singh A, Cai K, Kaura D, Wang E, Davatzikos C, Trojanowski JQ, Melhem ER, Marincola FM, Borthakur A. Haris M, et al. Neuroimage Clin. 2015 Feb 26;7:598-604. doi: 10.1016/j.nicl.2015.02.016. eCollection 2015. Neuroimage Clin. 2015. PMID: 25844314 Free PMC article. - Cognitive and Functional Consequence of Cardiac Arrest.
Perez CA, Samudra N, Aiyagari V. Perez CA, et al. Curr Neurol Neurosci Rep. 2016 Aug;16(8):70. doi: 10.1007/s11910-016-0669-y. Curr Neurol Neurosci Rep. 2016. PMID: 27311306 Review. - Role of structural MRI in Alzheimer's disease.
Vemuri P, Jack CR Jr. Vemuri P, et al. Alzheimers Res Ther. 2010 Aug 31;2(4):23. doi: 10.1186/alzrt47. Alzheimers Res Ther. 2010. PMID: 20807454 Free PMC article. - Should mild cognitive impairment be subtyped?
Hughes TF, Snitz BE, Ganguli M. Hughes TF, et al. Curr Opin Psychiatry. 2011 May;24(3):237-42. doi: 10.1097/YCO.0b013e328344696b. Curr Opin Psychiatry. 2011. PMID: 21346570 Free PMC article. Review. - Biomarkers in dementia: clinical utility and new directions.
Ahmed RM, Paterson RW, Warren JD, Zetterberg H, O'Brien JT, Fox NC, Halliday GM, Schott JM. Ahmed RM, et al. J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1426-34. doi: 10.1136/jnnp-2014-307662. Epub 2014 Sep 26. J Neurol Neurosurg Psychiatry. 2014. PMID: 25261571 Free PMC article. Review.
References
- Killiany RJ, Hyman BT, Gomez-Isla T, et al. MRI measures of entorhinal cortex versus hippocampus in preclinical AD. Neurology 2002;58:1188–1196. - PubMed
- Rusinek H, Endo Y, De Santi S, et al. Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology 2004;63:2354–2359. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical